Guberina, Nika
Kessler, Lukas
Pöttgen, Christoph
Guberina, Maja
Metzenmacher, Martin
Herrmann, Ken
Mucha, Maja
Rischpler, Christoph
Indenkämpen, Frank
Siveke, Jens T.
Treckmann, Jürgen
Umutlu, Lale
Kasper, Stefan
Fendler, Wolfgang P.
Stuschke, Martin
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 15 March 2022
Accepted: 13 September 2022
First Online: 28 September 2022
Competing interests
: J.T.S. receives honoraria as consultant or for continuing medical education presentations from AstraZeneca, Bayer, Immunocore, Roche, Servier. His institution receives research funding from Bristol-Myers Squibb, Celgene, Roche; He holds ownership and serves on the Board of Directors of Pharma 15, all outside the submitted work. All authors declare that there is no conflict of interest concerning the submitted work.